Combined corticosteroid and long-acting beta2 -agonist in one inhaler versus long-acting beta2 -agonists for chronic obstructive pulmonary disease-Reference-Cited by-同舟云学术

Combined corticosteroid and long-acting beta2 -agonist in one inhaler versus long-acting beta2 -agonists for chronic obstructive pulmonary disease

Published:2012-09-12 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Nannini Luis Javier¹,Lasserson Toby J²,Poole Phillippa³

Affiliation:

1. Hospital E Peron; Pulmonary Section; Ruta 11 Y Jm Estrada G. Baigorria Santa Fe - Rosario Argentina 2152

2. The Cochrane Collaboration; Cochrane Editorial Unit; 11-13 Cavendish Square London UK W1G 0AN

3. University of Auckland; Department of Medicine; Private Bag 92019 Auckland New Zealand

Publisher

Wiley

Subject

Pharmacology (medical)

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/14651858.CD006829.pub2/fullpdf

Reference144 articles.

1. Effect of fluticasone propionate/salmeterol (250/50) on COPD exacerbations and impact on patient outcomes;Anzueto;Journal of Chronic Obstructive Pulmonary Disease,2009

2. Borgstrom L Asking L Olsson H Peterson S Lack of interaction between disease severity and therapeutic response with budesonide/formoterol in a single inhaler [Abstract] American Thoracic Society 100th International Conference, May 21-26 2004 C22 [Poster 505]

3. Maintenance therapy with budesonide and formoterol in chronic obstructive pulmonary disease;Calverley;European Respiratory Journal,2003

4. Budesonide/formoterol reduces the use of oral corticosteroids in the treatment of COPD [Abstract];Calverley;European Respiratory Journal,2003

5. COPD exacerbations are reduced by budesonide/formoterol in a single inhaler [Abstract];Calverley;European Respiratory Journal,2003

Cited by 184 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Mnemonic for Management of Stable Chronic Obstructive Pulmonary Disease: A Canadian Approach;The Journal for Nurse Practitioners;2024-09

2. Network meta-analysis of the efficacy and safety of monoclonal antibodies and traditional conventional dichotomous agents for chronic obstructive pulmonary disease;Frontiers in Medicine;2024-02-13

3. National Development in the Use of Inhaled Corticosteroid Treatment in Chronic Obstructive Pulmonary Disease: Repeated Cross-Sectional Studies from 1998 to 2018;Biomedicines;2024-02-05

4. Risk of Pneumonia in Patients with COPD Initiating Fixed Dose Inhaled Corticosteroid (ICS) / Long-Acting Bronchodilator (LABD) Formulations Containing Extrafine Beclometasone Dipropionate versus Patients Initiating LABD Without ICS;Pragmatic and Observational Research;2024-01

5. Association between use of transdermal tulobuterol and short-term outcomes in patients with stroke and underlying chronic obstructive pulmonary disease: A retrospective cohort study;Medicine;2023-09-22